John D. Manders's most recent trade in Surmodics, Inc. was a trade of 8,155 Common Stock done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 8,155 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,810 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,584 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,160 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 1,862 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 1,740 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 152 | 8,155 (0%) | 0% | 39.9 | 6,066 | Common Stock |
| Surmodics Inc | D. John Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 387 | 8,307 (0%) | 0% | 39.4 | 15,267 | Common Stock |
| Surmodics Inc | John Manders D. | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 3,160 | 3,160 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Manders D. John | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,486 | 8,319 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | D. John Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 212 | 6,833 (0%) | 0% | 32.8 | 6,958 | Common Stock |
| Surmodics Inc | Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 175 | 7,045 (0%) | 0% | 32.8 | 5,744 | Common Stock |
| Surmodics Inc | Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 68 | 7,220 (0%) | 0% | 32.8 | 2,232 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 4,810 | 4,810 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 2,075 | 6,787 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 175 | 4,712 (0%) | 0% | 36.1 | 6,323 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 69 | 4,887 (0%) | 0% | 36.1 | 2,493 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 61 | 4,956 (0%) | 0% | 36.0 | 2,197 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,584 | 4,584 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 1,707 | 4,740 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 68 | 3,033 (0%) | 0% | 43.9 | 2,987 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 61 | 3,146 (0%) | 0% | 47.9 | 2,919 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.78 per share. | 25 Nov 2021 | 45 | 3,101 (0%) | 0% | 45.8 | 2,060 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 11 Aug 2021 | 2,608 | 5,716 (0%) | 0% | 23.0 | 59,854 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 2,608 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 53.33 per share. | 11 Aug 2021 | 2,555 | 3,161 (0%) | 0% | 53.3 | 136,261 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 54.25 per share. | 11 Aug 2021 | 53 | 3,108 (0%) | 0% | 54.2 | 2,875 | Common Stock |
| Surmodics Inc | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.45 per share. | 17 Jul 2021 | 31 | 3,108 (0%) | 0% | 53.5 | 1,657 | Common Stock |